MDR Amendment Proposal Likely To Be Adopted In Two Weeks’ Time
Executive Summary
Amending the MDR to stem the flow of medtech products being withdrawn from the market has long been seen as urgent. It looks like the EU is keeping its foot on the accelerator to adopt its latest proposal despite concerns raised about the text.
You may also be interested in...
European Parliament Edges Closer To Adopting MDR Transition Proposal
The European Parliament voted in favor of using an accelerated process to adopt the European Commission’s proposed extension timelines for legacy devices in the context of the Medical Device Regulation and the removal of the “sell-off” date, which also applies to some IVDs.
Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament
The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.